Menu

Image of the Day: Not All Bad

In zebrafish, some amount of reactive oxygen species is required for normal development.

Jul 16, 2018
Sukanya Charuchandra
The eye of a zebrafish embryo with an enlarged ganglion cell layer (green)
daniel suter/purdue uNiversity

Reactive oxygen species (ROS) levels are known to rise in times of stress or disease, leading to cellular damage, even going so far as cancer. However, ROS are needed to some extent for the formation of the nervous system in zebrafish, according to a study published in The Journal of Neuroscience on June 27.

In two separate experiments, researchers used a drug and CRISPR to shut down an enzyme known to produce ROS in zebrafish embryos. With both methods, they found an absence of the enzyme, meaning fewer ROS, led to defective visual signaling and other development. 

“We think there’s an ideal intermediate concentration [of ROS], but neither extreme is good,” coauthor Daniel Suter, a professor of biological sciences at Purdue University, says in a statement.

C.J. Weaver et al., “nox2/cybb deficiency affects zebrafish retinotectal connectivity,” J Neurosci, doi:10.1523/JNEUROSCI.1483-16.2018, 2018.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.